RubrYc Therapeutics
San Ramon
About RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to decode therapeutically significant protein interfaces, revolutionizing the discovery of antibody-based drugs. RubrYc Therapeutics using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies. Inspired by recent advancements in molecular library synthesis, massively parallel screening and computing, they are forging a new path for information-driven discovery of therapeutic antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $17.5M
- Funding stage: M&A
- Last round: Series A (Aug 2021)
- Website: rubryc.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rubryc-therapeutics-75047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.